Odronextamab
Odronextamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Odronextamab is under investigation in clinical trial NCT03888105 (Assess the Anti-tumor Activity and Safety of Odronextamab in Patients With Relapsed or Refractory B-cell Non-hodgkin Lymphoma).
| Trade Name | Odronextamab |
| Generic | Odronextamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Odronextamab
